Patents/Assignees

AXSOME THERAPEUTICS, Inc.

45 patents in portfolio

US12128052utility2024
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US12115165utility2024
Use of Reboxetine to Treat Narcolepsy
0 cites
US12102606utility2024
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
0 cites
US12005118utility2024
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11998552utility2024
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11957686utility2024
Compositions for Delivery of Reboxetine
0 cites
US11944683utility2024
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11883408utility2024
Reboxetine to Treat Narcolepsy
0 cites
US11865117utility2024
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11826354utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11826370utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11806354utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11801250utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11786488utility2023
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
0 cites
US11759522utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11738085utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11712441utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11660274utility2023
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
0 cites
US11628173utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites
US11617755utility2023
Pharmaceutical Compositions Comprising Meloxicam
0 cites

← PreviousPage 2 of 3Next →